|
Just wondering what equation to use to work about a and c? 3. A competitive antagonist of the CB1 receptor, SR141716A, has an equilibrium binding affinity constant (KN) for the CB1 receptor of approximately 5.6 x 109 M-1. (This is the information from the question prior: THC binds to the CB1 cannabinoid receptor and causes receptor activation, leading to a range of intracellular signals through an array of G proteins. THC binds to CB1 with a dissociation constant (Kd) of 0.0353 mM) |
|
|
Answer:
The answer could be attempted by using the dissociation constants of both substrate and inhibitor. The dissociation constant (Kd) quantifies the equilibrium between a ligand (S) being free in solution and bound to a site in a protein (ES).
[ES] --> [E] [S] Here, dissociation constant Kd = [E] [S]/ [ES]
In the question, dissociation constant of substrate (THC) is given, Kd = 0.0353 X 10-3 M
The dissociation constant of the inhibitor (Ki) would be the inverse of binding affinity constant (KN).
Ki = 1/KN = 1/5.6 X 109 M, answer is => Ki = 1.8 X 10-10 M.
Now that we have the values of dissociation constants for both substrate and inhibitor, we can get an estimate of their relative binding in the following manner:
Kd = [E] [S]/ [ES]; Ki = [E] [I]/ [EI]
hence, Kd/Ki = [E] [S] [EI]/ [E] [I] [ES]
i.e., Kd/Ki = [EI] [S]/ [ES] [I]
hence, [EI]/ [ES] = Kd [I]/Ki [S]
Now, let’s solve for a.) [EI]/ [ES] = Kd [I]/Ki [S]
So, [EI]/ [ES] = (0.0353 X 10-3)(5 X 10-8) / (1.8 X 10-10)(85 X 10-9)
i.e., [EI]/ [ES] = 1.15 X 105
It is important to consider that the total amount of enzyme present [Et], if we assume saturation, would be [Et] = [EI] + [ES]. Also, from the result just obtained, [EI] = 1.15 X 105 [ES].
So, the fraction of enzyme occupied by substrate would be [ES] / [Et] = [ES] / [EI] + [ES]
Hence, [ES] / [Et] = [ES] / (1.15 x 105 + 1) [ES]
So, [ES] / [Et] = 1 / 1.15 X 105 (as 1.15 X 105 >>> 1, we can disregard 1)
Hence, [ES] / [Et] = 8.7 X 10-6 [percentage of [ES] / [Et] = 0.00087%]
I am unable to suggest a method to solve part c. This is because to estimate how much inhibitor would be required, we would have to find out the level of saturation attained at the given substrate concentration. It can not be done without knowing certain other parameters such as Km/Kcat, which are not provided here.
Just wondering what equation to use to work about a and c? 3. A competitive antagonist...
Question 1 (1 point) Vasoconstriction occurs when epinephrine (adrenaline) binds to the a-adrenergic receptor on vascular smooth muscle cells. One way to treat high blood pressure is to administer competitive inhibitors that bind to this receptor. The Kd for binding of epinephrine to this receptor is ~UM. Based on the measured affinity (Kd) of the following drugs for the a-adrenergic receptor, which might be good candidates for high blood pressure medication? Drug A: Kd = 0.6 M; Drug B: Kd...
1. According to the paper, what does lactate dehydrogenase
(LDH) do and what does it allow to happen within the myofiber? (5
points)
2. According to the paper, what is the major disadvantage of
relying on glycolysis during high-intensity exercise? (5
points)
3. Using Figure 1 in the paper, briefly describe the different
sources of ATP production at 50% versus 90% AND explain whether you
believe this depiction of ATP production applies to a Type IIX
myofiber in a human....